NCT00645593 Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer Status COMPLETED Phase PHASE2
NCT00644488 A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT00643851 An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets Status COMPLETED Phase PHASE3
NCT00643201 Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Status COMPLETED Phase PHASE3
NCT00639834 Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00636168 Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma Status COMPLETED Phase PHASE3
NCT00634452 Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00633893 Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Status COMPLETED Phase PHASE3
NCT00633789 Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types Status COMPLETED Phase PHASE2
NCT00627978 Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons Status COMPLETED Phase PHASE2
NCT00624585 Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts Status COMPLETED Phase NA
NCT00623766 Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases Status COMPLETED Phase PHASE2
NCT00619190 Study of Aripiprazole to Treat Children and Adolescents With Autism Status COMPLETED Phase PHASE2
NCT00614939 Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment Status COMPLETED Phase PHASE3
NCT00611858 Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Status TERMINATED Phase PHASE2
NCT00608543 Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression Status COMPLETED Phase PHASE4